PHARMA SIGNALOPEN RESEARCH PLATFORM →
MHRASafety / PharmacovigilancePLATFORM PUBLISHED 2026-08-26

Increased risk of wear and corrosion identified with certain cobalt chrome modular neck hip replacements

The MHRA identified increased risk of wear and corrosion in cobalt‑chrome dual‑taper modular neck hip replacement systems, affecting devices from five manu…

Impact analysis · 35/100 · AI-assisted priority

This score prioritizes research; it does not predict an outcome. Method and limitations.

What happened

The MHRA identified increased risk of wear and corrosion in cobalt‑chrome dual‑taper modular neck hip replacement systems, affecting devices from five manufacturers used in the UK between 2007 and 2019. As a precaution, NHS trusts and hospitals are advised to identify and invite approximately 750 patients with these implants for clinical review. The action is a safety recommendation.

Quantitative evidence

Key Numbers
  • Approximately 750 patients currently have affected devices implanted
  • Devices available in the UK between 2007 and 2019
  • More than 100,000 hip replacements of all types performed annually in UK

Affected entities

dual‑taper modular neck hip replacement systems by Aesculap AGdual‑taper modular neck hip replacement systems by LimaCorporatedual‑taper modular neck hip replacement systems by Smith and Nephewdual‑taper modular neck hip replacement systems by Strykerdual‑taper modular neck hip replacement systems by Symbios

Analysis

The following contextual analysis is AI-assisted and separated from the reported primary-source record above.

Scientific context

The action signals growing concern over corrosion at modular neck junctions in hip implants, reflecting known risks of mechanically assisted crevice corrosion at metal interfaces.

Market context

Since multiple manufacturers are named and devices are no longer available, economic impact is limited to recall logistics and follow‑up of approximately 750 patients.

Legal and regulatory context

The MHRA’s measure is a safety recommendation advising clinical review; this does not impose enforcement but follows previous device safety communications.

Sources

For informational use only. Verify decisions against the linked regulator or primary source.

Evidence & limits

Source: Open the source record

Record identifier
fdada7afb561e6793bfba79e6350829f170648b466507ca28bfb1e3198c04108
Event / action date
Not separately retained
Source update date
Not separately retained
Platform retrieval / processing date
2026-08-26T13:09:13Z

What it supports. The linked authority’s action, within the product, indication, jurisdiction, and procedural stage stated in that record.

Limits. A committee opinion, draft, or announcement does not by itself establish final authorization. The summary and contextual analysis are AI-assisted; a source link does not establish human review.

Connection basis. Related profiles are normalized name mentions in article text. A mention does not establish a legal relationship.

What this record means · Report an issue with this record